Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Pujol, B*" or (type exact bookEditor and editor="Pujol, B*")

Add to list
- Journal Article
- A1
- open access
Solutions for archiving data in long-term studies : a reply to Whitlock et al.

James A Mills, Céline Teplitsky, Beatriz Arroyo, Anne Charmantier, Peter H Becker, Tim R Birkhead, Pierre Bize, Daniel T Blumstein, Christophe Bonenfant, Stan Boutin, et al.

(2016) TRENDS IN ECOLOGY & EVOLUTION. 31(2). p.85-87
Add to list
Archiving primary data: solutions for long-term studies

James A Mills, Céline Teplitsky, Beatriz Arroyo, Anne Charmantier, Peter H Becker, Tim R Birkhead, Pierre Bize, Daniel T Blumstein, Christophe Bonenfant, Stan Boutin, et al.

(2015) TRENDS IN ECOLOGY & EVOLUTION. 30(10). p.581-589
Add to list
A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice

Simon Van Belle (UGent) , A Swieboda-Sadlej, C Karanikiotis, JL Labourey, A Galid, T Wheeler, B Pujol and JG Aerts

(2012) CURRENT MEDICAL RESEARCH AND OPINION. 28(7). p.1079-1087
Add to list
Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study

JG Aerts, A Swieboda-Sadlej, C Karanikiotis, JL Labourey, A Galid, T Wheeler, B Pujol and Simon Van Belle (UGent)

(2012) CURRENT MEDICAL RESEARCH AND OPINION. 28(7). p.1089-1099
Add to list
Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy: data from the CHOICE study

Simon Van Belle (UGent) , C Karanikiotis, JL Labourey, A Galid, T Wheeler and B Pujol

(2011) CURRENT MEDICAL RESEARCH AND OPINION. 27(5). p.987-994
Add to list
- Conference Paper
- C3
Darbepoetin alfa effectiveness in breast cancer patients: data from the CHOICE study

Simon Van Belle (UGent) , C Karanikiotis, JL Labourey, A Galid, T Wheeler and B Pujol

(2011) BREAST. 20(suppl. 1). p.S81-S81
Add to list
- Conference Paper
- C3
Use of darbepoetin alfa for the treatment of chemotherapy-induced anaemia in European clinical practice: data from the CHOICE study

Simon Van Belle (UGent) , A Galid, C Karanikiotis, T Wheeler, B Pujol and JL Labourey

(2011) EUROPEAN JOURNAL OF CANCER. 47(suppl. 1). p.S265-S265
Add to list
Cost analysis of anemia treatment with erythropoiesis-stimulating agents (ESAS) in cancer patients receiving chemotherapy in Italy

A Duran, E Spaepen, M Lamotte, C Lucioni, L Kutikova, B Pujol, M Gozzo and Lieven Annemans (UGent)

(2011) VALUE IN HEALTH. 14(7). p.A439-A440
Add to list
Cost analysis of anemia treatment with erythropoieses-stimulating agents (ESAS) in cancer patients receiving chemotherapy: a multicountry approach

A Duran, E Spaepen, M Lamotte, E Walter, C Lucioni, B Pinheiro, M Brosa, L Kutikova, B Pujol and Lieven Annemans (UGent)

(2011) VALUE IN HEALTH. 14(3). p.A60-A60

Academic Bibliography

Solutions for archiving data in long-term studies : a reply to Whitlock et al.

Archiving primary data: solutions for long-term studies

A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice

Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study

Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy: data from the CHOICE study

Darbepoetin alfa effectiveness in breast cancer patients: data from the CHOICE study

Use of darbepoetin alfa for the treatment of chemotherapy-induced anaemia in European clinical practice: data from the CHOICE study

Cost analysis of anemia treatment with erythropoiesis-stimulating agents (ESAS) in cancer patients receiving chemotherapy in Italy

Cost analysis of anemia treatment with erythropoieses-stimulating agents (ESAS) in cancer patients receiving chemotherapy: a multicountry approach

Contents

Support

Contact